IHH Annual Report 2024

119 SIGNIFICANT EVENTS Significant events during the financial year are as disclosed in notes 36 and 37 to the financial statements. SUBSEQUENT EVENT Significant event subsequent to the end of the reporting period is as disclosed in note 42 to the financial statements. CONSOLIDATION OF SUBSIDIARIES WITH DIFFERENT FINANCIAL YEAR END Pursuant to Section 247(7) of the Companies Act 2016, the Company has applied and has been granted approval by the Companies Commission of Malaysia for the following subsidiaries of the Company to continue to have or to adopt a financial year which does not coincide with the Company in relation to the financial year ended 31 December 2024: • Parkway Healthcare India Private Limited • Andaman Alliance Healthcare Limited (under members’ voluntary liquidation) • Gleneagles Healthcare India Private Limited (“GHIPL”) and its subsidiaries (“GHIPL Group”) • Fortis Healthcare Limited (“Fortis”) and its subsidiaries (“Fortis Group”) The details of the subsidiaries of GHIPL and Fortis are disclosed in note 38 to the financial statements. AUDITORS The auditors, KPMG PLT have indicated their willingness to accept re-appointment. The auditors' remuneration is disclosed in note 25 to the financial statements. Signed on behalf of the Board of Directors in accordance with a resolution of the Directors: Tan Sri Dr Nik Norzrul Thani Bin N. Hassan Thani Director Chua Bin Hwee Director Date: 27 February 2025

RkJQdWJsaXNoZXIy NDgzMzc=